Type 1 diabetes is particularly a serious disease and its management has been a journey fraught with various challenges. But MIT engineering announces a revolution in the treatment of diabetes which can be potentially transformative. This innovation is an implantable device, containing not only insulin-producing cells but also its own oxygen production factory. It is incredible that this device is capable of producing oxygen by splitting the user’s vapor. This is a phenomenal feat, with its posi

MIT engineers have developed an implantable device for Type 1 diabetes treatment. The device contains insulin-producing cells and self-generates oxygen by splitting bodily water vapor. Promising results in diabetic mice show stabilized glucose levels. This advancement could eliminate daily insulin injections, offering a groundbreaking solution for diabetes management.

  • MushuChupacabra@lemmy.world
    15·
    1 year ago

    Oxygen and carbon dioxide exchange happens at the capillary level, where red blood cells squeeze through one blood cell at a time. The fact that the red blood cells are physically pressed up against the capillary walls, is a mechanical requirement to help strip oxygen off of hemoglobin and to dump carbon dioxide at the same binding site.

    You’d basically need to grow organs and tissue capable of that gas exchange, at which point you’d be at the endgame of simply replacing defective organs and glands with actual organs and glands, instead of a manufactured pseudo gland.